Clinical Trials Directory

Trials / Completed

CompletedNCT00666822

Compliance to a Hormone Therapy Regimen in Breast Cancer

Adherence to Endocrine Therapy in Women With Breast Cancer in Clinical Practice Settings

Status
Completed
Phase
Study type
Observational
Enrollment
178 (actual)
Sponsor
Case Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Understanding how well patients comply with their treatment regimen may help doctors plan the best treatment and ongoing care. PURPOSE: This clinical trial is studying whether patients comply with their hormone therapy regimen in women with estrogen receptor-positive stage I, stage II, or stage IIIA breast cancer.

Detailed description

OBJECTIVES: Primary * To examine the relationship between adherence to endocrine therapy and variables from the Health Belief Model (i.e., perceived risk, barriers to and benefits of adherence, and cues to action such as physician recommendation) as well as measures of patient's perceptions of patient- and family-centered care in women with estrogen receptor-positive stage I-IIIA breast cancer. OUTLINE: Patients complete a 15 minute questionnaire on-line or by mail comprising questions of demographic and medical variables (i.e., age, race/ethnicity, marital and educational status, and medication side effects) as well as health beliefs and selected aspects of patient- and family-centered care. Data collected from the questionnaire will be stored in an Excel database. Patient's medical records are reviewed for information about the time since diagnosis, tumor characteristics, treatment, and comorbidity.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcompliance monitoringTo examine the relationship between adherence to endocrine therapy and variables from the Health Belief Model (i.e., perceived risk, barriers to and benefits of adherence, and cues to action such as physician recommendation) as well as measures of patient's perceptions of patient- and family-centered care in women with estrogen receptor-positive stage I-IIIA breast cancer.
OTHERmedical chart reviewPatient's medical records are reviewed for information about the time since diagnosis, tumor characteristics, treatment, and comorbidity.
OTHERquestionnaire administrationPatients complete a 15 minute questionnaire on-line or by mail comprising questions of demographic and medical variables (i.e., age, race/ethnicity, marital and educational status, and medication side effects) as well as health beliefs and selected aspects of patient- and family-centered care. Data collected from the questionnaire will be stored in an Excel database.

Timeline

Start date
2007-12-01
Primary completion
2009-09-01
Completion
2015-12-01
First posted
2008-04-25
Last updated
2016-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00666822. Inclusion in this directory is not an endorsement.